Welcome to LookChem.com Sign In|Join Free
  • or
(4-Hydroxybenzyl)-succinic acid, also known as 4-(4-hydroxybenzyl)succinic acid or 4-(4-hydroxyphenylmethyl)butanedioic acid, is a chemical compound with the molecular formula C11H12O5. It is a white crystalline solid that is soluble in water and has a molecular weight of 224.21 g/mol. (4-hydroxybenzyl)-succinic acid is derived from succinic acid, a dicarboxylic acid, with a 4-hydroxybenzyl group attached to its backbone. It is used in various applications, including pharmaceuticals, as a building block for the synthesis of more complex molecules, and in the production of certain drugs and agrochemicals. Its chemical structure features a central succinic acid core with a hydroxybenzyl group attached to the fourth carbon, which contributes to its reactivity and potential applications in organic synthesis.

7418-24-8

Post Buying Request

7418-24-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7418-24-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7418-24-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,4,1 and 8 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7418-24:
(6*7)+(5*4)+(4*1)+(3*8)+(2*2)+(1*4)=98
98 % 10 = 8
So 7418-24-8 is a valid CAS Registry Number.

7418-24-8Downstream Products

7418-24-8Relevant academic research and scientific papers

Mechanism of benzylsuccinate synthase probed by substrate and isotope exchange

Li, Lei,Marsh, E. Neil G.

, p. 16056 - 16057 (2006)

Benzylsuccinate synthase catalyzes the first step in the anaerobic metabolism of toluene through an unusual reaction in which toluene is added to fumarate to produce (R)-benzylsuccinate. We have exploited the broad substrate range of the enzyme to demonst

Factor VIIa inhibitors: Improved pharmacokinetic parameters

Kolesnikov, Aleksandr,Rai, Roopa,Young, Wendy B.,Mordenti, Joyce,Liu, Liang,Torkelson, Steven,Shrader, William D.,Leahy, Ellen M.,Hu, Huiyong,Gjerstad, Erik,Janc, James,Katz, Bradley A.,Sprengeler, Paul A.

, p. 2243 - 2246 (2007/10/03)

Efforts to improve the potency and pharmacokinetic properties of small molecule factor VIIa inhibitors are described. Small structural modifications to existing leads allow the modulation of half-life and clearance, potentially making these compounds suitable candidates for drug development.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7418-24-8